Trials / Conditions / Advanced Malignant Pleural Mesothelioma

Advanced Malignant Pleural Mesothelioma

4 registered clinical trials studyying Advanced Malignant Pleural Mesothelioma.

Status	Trial	Sponsor	Phase
Terminated	Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma NCT04166734	Royal Marsden NHS Foundation Trust	Phase 1
Terminated	A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Fol NCT01769547	Ontario Clinical Oncology Group (OCOG)	Phase 2
Completed	Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM NCT01358084	AGC Biologics S.p.A.	Phase 2
Unknown	Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothel NCT01869023	Instituto Nacional de Cancerologia de Mexico	Phase 2